Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2021-04-26 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TOULOUSE (31400), Haute-Garonne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE MALEPERE : revenue, balance sheet and financial ratios
PHARMACIE MALEPERE is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TOULOUSE (31400),
this company of category PME
shows in 2023 a net income negative of -116 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE MALEPERE (SIREN 898784673)
Indicator
2023
2022
Revenue
N/C
N/C
Net income
-116 499 €
165 580 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE MALEPERE records a net loss of 116 k€. This deficit will reduce equity on the balance sheet.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-116 499 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at -1373%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
-1373.232%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
-6.162%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
Debt ratio
241.812
-1373.232
Financial autonomy
24.065
-6.162
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
-1373.232023
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Excellent-50 pts over 2 years
In 2023, the debt ratio of PHARMACIE MALEPERE (-1373.23) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
-6.16%2023
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of PHARMACIE MALEPERE (-6.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 256.37. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
256.369
Liquidity indicators evolution PHARMACIE MALEPERE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2022
2023
Liquidity ratio
402.744
256.369
Interest coverage
None
None
Sector positioning
Liquidity ratio
256.372023
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good
In 2023, the liquidity ratio of PHARMACIE MALEPERE (256.37) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE MALEPERE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE MALEPERE with other companies in the same sector:
Frequently asked questions about PHARMACIE MALEPERE
What is the revenue of PHARMACIE MALEPERE ?
The revenue of PHARMACIE MALEPERE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE MALEPERE profitable?
PHARMACIE MALEPERE recorded a net loss in 2023.
Where is the headquarters of PHARMACIE MALEPERE ?
The headquarters of PHARMACIE MALEPERE is located in TOULOUSE (31400), in the department Haute-Garonne.
Where to find the tax return of PHARMACIE MALEPERE ?
The tax return of PHARMACIE MALEPERE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE MALEPERE operate?
PHARMACIE MALEPERE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart